News
2026.10.13
Presentation of the research results of Healios’ Dual CAR-eNK cells targeting EGFR and PD-L1 for glioblastoma at iPSC 20th Anniversary Symposium (Repost)
Healios will make poster presentations of our research results of Engineered human iPSC-derived Dual CAR-NK (Healios’ Dual CAR-eNK) cells targeting EGFR and PD-L1 for glioblastoma at iPSC 20th Anniversary Symposium in Kyoto, Japan from October 20 to 22, 2026. We will present a poster for Dual CAR eNK cells. Please see below for details.
“Presentation of the research results of Healios’ Dual CAR-eNK cells
targeting EGFR and PD-L1 for glioblastoma at iPSC 20th Anniversary Symposium”